SPFI Heads Into Earnings With Insider Sales and a Clean Short Book
Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
South Plains Financial reports Q3 results on October 22, three days away, with the most notable feature of this week's setup not the shorts but the insider register.
Directors have been net sellers to the tune of roughly $12.8 million worth of stock across the past 90 days, none of it under a pre-arranged 10b5-1 plan. Director Richard Campbell sold 160,000 shares across two days in early August for just over $7.1 million. Director James Stein sold 100,000 shares on July 28 for around $4.5 million. These are discretionary open-market sales made above current levels, the stock is at $43.53 today after a month that saw it give back about 2%, and both directors sold in the low-to-mid $44s. On the 13D/G register, Chairman and CEO Curtis Griffith filed an amended Schedule 13G in August reflecting a decline in his stake from 8.9% to 6.15%, though the June transaction coded as a disposition of 300,000 shares is the underlying move. None of the three largest insiders are accumulating.
Short interest does not tell an aggressive story. Bears hold roughly 3.5% of the free float, a position that has grown about 11% over the past month but remains modest in absolute terms. The borrow market is extremely loose: availability is running near 9,800%, meaning there are roughly 98 shares available to borrow for every one already lent out, the most relaxed the lending pool has been in at least a year against a 52-week low availability of 736%. Cost to borrow is 0.57%, essentially the general collateral rate. The ORTEX short score has drifted down from 39.8 on October 12 to 38.6 today, ranking in the 34th percentile of the universe. There is no squeeze pressure here and no evidence of a crowded short thesis building.
The Street remains constructive, even after the insider selling. Keefe Bruyette lifted its target to $50 following Q2 results in July, and Benchmark initiated coverage at $53 with a Buy in June. Piper Sandler holds an Overweight with a $46 target, set in April. The mean target of $50.50 implies about 16% upside from the current price, a respectable gap for a regional bank trading at 10.5x earnings and 1.15x book. The bull case centres on a 4% net interest margin, dominant deposit franchise in Lubbock, and post-BOH acquisition scale gains. Bears point to a securities-heavy balance sheet with $49 million of unrealized losses, fee income that has weakened since the insurance business was sold, and criticized loans that have climbed to $101 million, or 3.2% of the portfolio. The dividend score ranks in the 98th percentile, though the dividend history in the data runs only through mid-2022.
FDIC call report data from the Federal Deposit Insurance Corporation shows total assets have risen for four consecutive quarters to $5.39 billion, and total deposits have grown for the same four-quarter stretch to $4.72 billion. The ORTEX alt data layer has not yet accumulated enough history to test whether the FDIC figures lead South Plains' reported net income, so they are context rather than signal. The next print on October 22 will add a fifth data point to that streak, or interrupt it.
The nearest peer move this week is instructive for framing. HOMB rose 3.4% and UBSI gained 2.7% across the week, broadly in line with SPFI's 2.9% gain, suggesting the regional bank group has had a decent few days into the earnings window. The prior SPFI print in July produced a negligible one-day reaction before a 0.9% five-day gain; the one before that, in April, saw the stock jump 7.5% on the day. The pattern is uneven enough to make the October 22 reaction hard to frame from history alone.
What to watch: whether management commentary on the BOH integration timeline, criticized loan trends, and deposit cost flexibility shifts the Street's target cluster meaningfully above or below the current $46 to $53 range following Wednesday's release.
Stocks in this article
See the live data behind this article on ORTEX.
Open SPFI on ORTEX →How this article was generated
- Generated
- 19 Oct 2026, 17:37
- Data as of
- 19 Oct 2026, 17:37
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt Data
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.